Free Trial
LON:RENE

ReNeuron Group (RENE) Share Price, News & Analysis

ReNeuron Group logo

About ReNeuron Group Stock (LON:RENE)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
3.38
3.38
52-Week Range
N/A
Volume
177,373 shs
Average Volume
578,249 shs
Market Capitalization
£1.93 million
P/E Ratio
N/A
Dividend Yield
0.76%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RENE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ReNeuron Group and its competitors with MarketBeat's FREE daily newsletter.

RENE Stock News Headlines

One stock to replace Nvidia
Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.
ReNeuron Group PLC RENE
See More Headlines

RENE Stock Analysis - Frequently Asked Questions

ReNeuron Group plc (LON:RENE) released its quarterly earnings results on Monday, July, 20th. The company reported ($35.90) EPS for the quarter, beating analysts' consensus estimates of ($50.20) by $14.30.

Shares of RENE stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that ReNeuron Group investors own include 10094 (IRD.TO) (IRD), Sareum (SAR), ValiRx (VAL), IOG (IOG), Dignity (DTY), Tri-Star Resources plc (TSTR.L) (TSTR) and Sirius Minerals (SXX).

Company Calendar

Last Earnings
7/20/2020
Today
8/09/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Trading
Current Symbol
LON:RENE
CIK
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.09)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£5.07 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-106.77%
Return on Assets
-37.91%

Debt

Debt-to-Equity Ratio
14.25
Current Ratio
1.51
Quick Ratio
2.02

Sales & Book Value

Annual Sales
£783 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
0.61
Book Value
GBX 4 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
57,170,000
Free Float
N/A
Market Cap
£1.93 million
Optionable
Not Optionable
Beta
0.83
10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (LON:RENE) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners